Literature DB >> 25850546

A practical approach to avoiding iatrogenic Creutzfeldt-Jakob disease (CJD) from invasive instruments.

Paul Brown1, Michael Farrell2.   

Abstract

Potential Creutzfeldt-Jakob disease instrument-contamination events continue to occur, causing widespread hospital and patient concern. We propose the use of a combination of diagnostic tests (ie, spinal fluid for 14-3-3 protein or nasal brushing for misfolded prion protein) and instrument handling procedures (ie, using a regional set of dedicated instruments), which if applied to all patients admitted with symptoms of either dementia or cerebellar disease, should eliminate the risk of iatrogenic instrument infection.

Entities:  

Mesh:

Year:  2015        PMID: 25850546     DOI: 10.1017/ice.2015.53

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  11 in total

1.  Brain biopsies requiring Creutzfeldt-Jakob disease precautions in the Republic of Ireland 2005-2016.

Authors:  F M Brett; S Looby; A Chalissery; D Chen; C Heaney; J Heffernan; F Cunningham; R Howley; T Loftus; H Kearney; M A Farrell
Journal:  Ir J Med Sci       Date:  2017-08-12       Impact factor: 1.568

Review 2.  Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease.

Authors:  Gianluigi Zanusso; Salvatore Monaco; Maurizio Pocchiari; Byron Caughey
Journal:  Nat Rev Neurol       Date:  2016-05-13       Impact factor: 42.937

3.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

Review 4.  Human prion diseases: surgical lessons learned from iatrogenic prion transmission.

Authors:  David J Bonda; Sunil Manjila; Prachi Mehndiratta; Fahd Khan; Benjamin R Miller; Kaine Onwuzulike; Gianfranco Puoti; Mark L Cohen; Lawrence B Schonberger; Ignazio Cali
Journal:  Neurosurg Focus       Date:  2016-07       Impact factor: 4.047

5.  Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease.

Authors:  Anna Bartoletti-Stella; Patrizia Corrado; Nicola Mometto; Simone Baiardi; Pascal F Durrenberger; Thomas Arzberger; Richard Reynolds; Hans Kretzschmar; Sabina Capellari; Piero Parchi
Journal:  Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.590

6.  Three sporadic cases of Creutzfeldt-Jakob disease in China and their clinical analysis.

Authors:  Xingbang Wang; Na Li; Aifen Liu; Lin Ma; Peiyan Shan; Wenjing Jiang; Qun Zhang
Journal:  Exp Ther Med       Date:  2017-07-25       Impact factor: 2.447

7.  Creutzfeldt-Jakob Disease after Dental Procedure along with the Initial Manifestations of Psychiatric Disorder: A Case Report.

Authors:  Rahim Badrfam; Ahmad Ali Noorbala; Zahra Vahabi; Atefeh Zandifar
Journal:  Iran J Psychiatry       Date:  2021-01

8.  EBV driven natural killer cell disease of the central nervous system presenting as subacute cognitive decline.

Authors:  Francesca M Brett; Richard Flavin; Daphne Chen; Teresa Loftus; Seamus Looby; Allan McCarthy; Cillian de Gascun; Elaine S Jaffe; Nurul Nor; Mohsen Javadpour; Dominick McCabe
Journal:  Hum Pathol (N Y)       Date:  2017-11

9.  A direct assessment of human prion adhered to steel wire using real-time quaking-induced conversion.

Authors:  Tsuyoshi Mori; Ryuichiro Atarashi; Kana Furukawa; Hanae Takatsuki; Katsuya Satoh; Kazunori Sano; Takehiro Nakagaki; Daisuke Ishibashi; Kazuko Ichimiya; Masahisa Hamada; Takehisa Nakayama; Noriyuki Nishida
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379

10.  Inactivation of Prions and Amyloid Seeds with Hypochlorous Acid.

Authors:  Andrew G Hughson; Brent Race; Allison Kraus; Laura R Sangaré; Lori Robins; Bradley R Groveman; Eri Saijo; Katie Phillips; Luis Contreras; Virkamal Dhaliwal; Matteo Manca; Gianluigi Zanusso; Daniel Terry; Jeffrey F Williams; Byron Caughey
Journal:  PLoS Pathog       Date:  2016-09-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.